Keyphrases
COVID-19
100%
Randomized Controlled Trial
100%
Anti-inflammatory Effect
100%
Curcumin
100%
COVID-19 Infection
66%
Inflammatory Biomarkers
66%
Curcumin Supplementation
66%
Race-ethnicity
33%
Blood Samples
33%
Inflammatory Cytokines
33%
Interleukin-6
33%
Placebo
33%
Linear Regression
33%
Reinfection
33%
Twice Daily
33%
COVID-19 Vaccination
33%
Breakthrough Infection
33%
COVID-19 Diagnosis
33%
Between-group Difference
33%
Monocyte Chemoattractant protein-1 (MCP-1)
33%
Anti-inflammatory Activity
33%
Female Age
33%
Vaccine Dose
33%
Nutraceuticals
33%
Monovalent Vaccine
33%
Primary Series
33%
Trial Enrollment
33%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Curcumin
100%
Antiinflammatory Activity
100%
Biological Marker
75%
Infection
75%
Vaccination Policy
25%
Placebo
25%
Anti-Inflammatory Drug
25%
Cytokine
25%
Reinfection
25%
Nutraceutical
25%
Agricultural and Biological Sciences
Feed Supplementation
100%
Blood Sampling
50%
Interleukin 6
50%
Cytokine
50%
Placebo
50%
Nutraceutical
50%
Anti-Inflammatory Activity
50%
Neuroscience
Anti-Inflammatory
100%
Randomized Controlled Trial
100%
Curcumin
100%
Placebo
25%
Proinflammatory Cytokine
25%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Antiinflammatory Activity
100%
Proinflammatory Cytokine
50%
Interleukin-6
50%
Blood Sampling
50%
Immunology and Microbiology
COVID-19
100%
Antiinflammatory Activity
100%
Proinflammatory Cytokine
16%
Vaccine Efficacy
16%
Interleukin-6
16%
Vaccination Policy
16%
Breakthrough Infection
16%
Blood Sampling
16%